Lethal Giant Larvae 1 Tumour Suppressor Activity Is Not Conserved in Models of Mammalian T and B Cell Leukaemia

• Edwin D. Hawkins ,

  * E-mail: e.hawkins@imperial.ac.uk (EDH); sarah.russell@petermac.org (SMR)

  Current address: Imperial College London, London, United Kingdom

  Affiliations Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia, Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia

  ⨯
• Jane Oliaro,

  Affiliations Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia, Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia

  ⨯
• Kelly M. Ramsbottom,

  Affiliations Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia, Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia

  ⨯
• Stephen B. Ting,

  Affiliation Stem Cell Research Group, Australian Centre for Blood Diseases, Monash University and Alfred Health, Melbourne, Victoria, Australia

  ⨯
• Faruk Sacirbegovic,

  Affiliations Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia, Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia

  ⨯
• Michael Harvey,

  Affiliations Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia, Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia

  ⨯
• Tanja Kinwell,

  Affiliations Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia, Cell Cycle and Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

  ⨯
• Jacques Ghysdael,

  Affiliations Institut Curie, Centre Universitaire, Bat 110 91405, Orsay, France, Centre National de la Recherche Scientifique UMR 3306, Orsay, France, INSERM (Institut National de la Santé et de la Recherche Médicale) U1005, Orsay, France

  ⨯
• Ricky W. Johnstone,

  Affiliations Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia, Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia

  ⨯
• Patrick O. Humbert,

  Affiliations Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia, Cell Cycle and Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

  ⨯
• Sarah M. Russell

  * E-mail: e.hawkins@imperial.ac.uk (EDH); sarah.russell@petermac.org (SMR)

  Affiliations Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia, Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia, Centre for Micro-Photonics, Swinburne University of Technology, Hawthorn, Victoria, Australia

  ⨯